Litigation for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

US Court Litigation for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,043,230			2019-11-06	2024-03-22	35:271 Patent Infringement	District Court, D. Delaware	Plaintiff
6,043,230			2020-01-14	2020-01-28	15:0002 Antitrust Litigation	District Court, S.D. Florida	Plaintiff
6,043,230			2016-07-06	2018-04-25		Court of Appeals for the Federal Circuit
6,043,230			2019-05-14		15:1 Antitrust Litigation	District Court, N.D. California	Both

Patent Trial and Appeal Board Cases for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
5,922,695	Mylan Pharmaceuticals Inc.		2014-06-04	06-04-2014	Gilead Sciences, Inc.	Inter partes review		12-09-2014	MURTY ARIMILLI
5,935,946	MYLAN PHARMACEUTICALS INC.		2014-06-04	06-04-2014	Gilead Sciences, Inc.	Inter partes review		12-17-2014	JOHN MUNGER
5,977,089	Mylan Pharmaceuticals Inc.		2014-06-04	06-04-2014	Gilead Sciences, Inc.	Inter partes review		12-09-2014	MURTY ARIMILLI
6,043,230	Mylan Pharmaceuticals Inc.		2014-06-04	06-04-2014	Gilead Sciences, Inc.	Inter partes review		12-09-2014	MURTY ARIMILLI